ALVO Alvotech
ALVO Alvotech
Healthcare · Drug Manufacturers - Specialty & Generic
Market read
POC $3.75 · VWAP $4.55 · +0.7% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
ALVO Price Structure
Loading timeframes…
Peers
Every watchlist ALVO belongs to, members best 30-day change first — ALVO highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How ALVO's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about ALVO from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 18 days ago · Oct 5
- FDA approves additional U.S. manufacturing capacity for
- FDA greenlights SIMLANDI manufacturing in a second Reykjavik...
- Alvotech (NASDAQ:ALVO) Shares Gap Up - Still a Buy? - MarketBeat
- Newsroom - Alvotech
- Alvotech SA Stock Price Today | NASDAQ: ALVO Live - Investing.com
- ALVO Q2 2026 Earnings Report on 8/20/2026 - MarketBeat
ALVO research tape
24 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.